Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 20, Issue 2, pp. 263-273
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 4, 2020
- Revision received July 6, 2020
- Accepted November 9, 2020
- Published first December 2, 2020.
Article Versions
- Previous version (December 2, 2020 - 07:03).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Leslie A. Parsels1,#,
- Carl G. Engelke1,#,
- Joshua Parsels1,
- Sheryl A. Flanagan1,
- Qiang Zhang1,
- Daria Tanska1,
- Daniel R. Wahl1,
- Christine E. Canman2,
- Theodore S. Lawrence1, and
- Meredith A. Morgan1,*
- 1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
- 2Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan.
- ↵*Corresponding Author:
Meredith A. Morgan, University of Michigan, 1301 Catherine St., 4326B Med Sci I, Ann Arbor, MI 48109. Phone: 734-647-5928; Fax: 734-763-1581; E-mail: mmccrack{at}med.umich.edu
↵#L.A. Parsels and C.G. Engelke contributed equally to this article.
February 2021
Volume 20, Issue 2
Volume 20, Issue 2
Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination–Proficient Pancreatic Cancer
Jump to section
Advertisement